2021
DOI: 10.1186/s12936-021-03605-5
|View full text |Cite
|
Sign up to set email alerts
|

Low prevalence of highly sulfadoxine‐resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin

Abstract: Background In 2004, in response to high levels of treatment failure associated with sulfadoxine-pyrimethamine (SP) resistance, Benin changed its first-line malaria treatment from SP to artemisinin-based combination therapy for treatment of uncomplicated Plasmodium falciparum malaria. Resistance to SP is conferred by accumulation of single nucleotide polymorphisms (SNPs) in P. falciparum genes involved in folate metabolism, dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps), … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 46 publications
1
4
0
Order By: Relevance
“…These results could be explained by high drug pressure, as sulfadoxine pyrimethamine has been used in Niger in the chemoprevention of malaria in pregnant women and children for several years [11]. Our results match those found in other countries in Africa [24][25][26][27][28][29]. In countries with high drug pressure, these mutations are the main cause of decreased sulfadoxine pyrimethamine efficacy [30,31].…”
Section: Discussionsupporting
confidence: 83%
“…These results could be explained by high drug pressure, as sulfadoxine pyrimethamine has been used in Niger in the chemoprevention of malaria in pregnant women and children for several years [11]. Our results match those found in other countries in Africa [24][25][26][27][28][29]. In countries with high drug pressure, these mutations are the main cause of decreased sulfadoxine pyrimethamine efficacy [30,31].…”
Section: Discussionsupporting
confidence: 83%
“…Notably, according to our study, the novel mutation I431V, which has been widespread in Nigeria in recent years ( 32 ), has emerged in more African countries ( 23 , 33 , 34 ). We detected it in isolates from seven of the eight countries from which malaria was exported, especially in Chad (20.00%), Equatorial Guinea (10.81%), Congo DR (9.09%), Cameroon (8.47%), and Congo (8.33%).…”
Section: Discussionmentioning
confidence: 62%
“…The octal mutant genotype which combines the Pfdhfr N51I, C59R, S108N and Pfdhps I431V, S436A, A437G, A581G, A613S (IRN/VAGKGS) could be strongly associated with SP failure in Central Africa for which the efficacy of IPTp-SP may be limited [ 9 ]. However, its role in parasite resistance to SP has yet to be described [ 51 ].…”
Section: Introductionmentioning
confidence: 99%